How long do you treat recurrent classical Hodgkin lymphoma with brentuximab/nivolumab if the patient does not want to proceed to BMT?  


Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at SOUTH TEXAS ONCOLOGY AND HEMATOLOGY
Thank you 
Sign in or Register to read more